The cost of Medicare-funded medical and pharmaceutical services for mental disorders in children and adolescents in Australia
Open Access
- 9 April 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (4), e0249902
- https://doi.org/10.1371/journal.pone.0249902
Abstract
To examine the health care costs associated with mental disorders and subthreshold mental disorders within a nationally representative sample of children and adolescents in Australia. Data were derived from the Young Minds Matter Survey (N = 6,310). Mental disorders were classified using the Diagnostic Interview Schedule for Children Version IV. Participant data were linked to administrative data on health care costs. Adjusted generalized linear regression models and two-part models were used to estimate mean differences in costs between those with a mental disorder or subthreshold disorder and those without. Costs associated with health care attendances and medications were higher for children and adolescents with mental disorders and subthreshold mental disorders compared to those without a mental disorder. The additional population health care costs due to mental disorders amounted to AUD$234 million annually in children and adolescents, of which approximately 16% was attributed to out-of-pocket costs. Findings showed that those with subthreshold mental disorders or comorbid mental disorders have substantial additional costs of Medicare-funded medical and pharmaceutical services. Mental disorders in children and adolescents are associated with significant health care costs. Further research is needed to ensure that this population is receiving effective and efficient care.Funding Information
- Deakin University (School of Health and Social Development)
This publication has 25 references indexed in Scilit:
- Key findings from the second Australian Child and Adolescent Survey of Mental Health and WellbeingAustralian & New Zealand Journal of Psychiatry, 2015
- Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force ReportValue in Health, 2015
- Treatment patterns and short‐term outcomes in an early intervention youth mental health serviceEarly Intervention in Psychiatry, 2014
- Annual Research Review: Child and adolescent mental health interventions: a review of progress in economic studies across different disordersJournal of Child Psychology and Psychiatry, 2014
- Health Care Costs Associated With Parent-Reported ADHD: A Longitudinal Australian Population–Based StudyJournal of Attention Disorders, 2013
- The cost of healthcare for children with mental health difficultiesAustralian & New Zealand Journal of Psychiatry, 2013
- The economic cost of brain disorders in EuropeEuropean Journal of Neurology, 2011
- Comorbidity in Australia: Findings of the 2007 National Survey of Mental Health and WellbeingAustralian & New Zealand Journal of Psychiatry, 2009
- Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New DataJournal of Child and Adolescent Psychopharmacology, 2007
- NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, Differences From Previous Versions, and Reliability of Some Common DiagnosesJournal of the American Academy of Child & Adolescent Psychiatry, 2000